Patient Empowerment Through Predictive Personalised Decision Support

  • Research type

    Research Study

  • Full title

    Patient Empowerment Through Predictive Personalised Decision Support (PEPPER)\n

  • IRAS ID

    219566

  • Contact name

    Nick Oliver

  • Contact email

    nick.oliver@imperial.ac.uk

  • Sponsor organisation

    Imperial College London

  • Duration of Study in the UK

    3 years, 0 months, 0 days

  • Research summary

    Patient Empowerment through Predictive PERsonalised decision support (PEPPER) is an EU-funded research project to develop a personalised clinical decision support system for Type 1 diabetes mellitus (T1DM) self-management. The tool provides insulin bolus dose advice, tailored to the needs of individuals. The system uses Case-Based Reasoning (CBR), an artificial intelligence methodology that adapts to new situations according to past experience. The PEPPER system also incorporates a safety module that promotes safety by providing glucose alarms, low-glucose insulin suspension, carbohydrate recommendations and fault detection. \n\nThe principal research objectives are to assess the usability, safety, and technical proof of concept and feasibility of the PEPPER in participants with T1DM. Prior to starting the clinical trials a detailed usability study of the PEPPER system will be conducted. Evaluation of safety is a priority and will be assessed throughout the clinical studies. The safety components only of the PEPPER system will initially be evaluated in a 6-week clinical study in an out-of-clinic environment (phase 1) and will measure incidence and percentage time spent in hypoglycaemia, evaluate usability and incidence of technical faults. Following the initial safety study, the overall PEPPER system (integrated with the CBR algorithm) will be assessed over 6 weeks (phase 2) and the primary outcome will be percentage time spent in hypoglycaemia. The final phase (phase 3) will aim to investigate the feasibility and clinical efficacy of the PEPPER system compared to a standard bolus calculator.

  • REC name

    London - Bloomsbury Research Ethics Committee

  • REC reference

    17/LO/0939

  • Date of REC Opinion

    14 Jun 2017

  • REC opinion

    Favourable Opinion